BCL2 and cancer: Exosomes can convey biomarkers of cancer metastasis inhibition, such as miR-140-3p (which upregulate the expression of BCL9 and BCL2) and circFNDC3B (which inhibit miR-937-5p and upregulate TIMP3) in colorectal cancer [155,156].